Short term antibiotic therapy in Patients with cholangitis and complete biliary drainage: A prospective trial

Short term antibiotic therapy in Patients with cholangitis and complete biliary drainage: A prospective trial - ProCom-Trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021237

Enrollment

105

Registered

2020-11-05

Start date

2020-07-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K83.0

Interventions

Group 1: Patients will be contacted after 4 weeks to exclude occurence or recurrent cholangitis.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with Diagnosis of Cholangitis I° and II° (Tokyo Guidelines 2018) and after ERCP with stent insertion and sufficient biliary drainage 2. Antibiotic treatment according to Tokyo Guidelines 2018

Exclusion criteria

Exclusion criteria: 1. Age <18J. 2. Already participated at this study 3. Insufficient biliary drainage 4. Septic patient (IMC-pflichtig, Cholangitis III°) 5. Concomittant acute biliary pancreatitis 6. Concomittant decompensated comorbidity 7. Concomittant infection of other etiology 8. Dialysis 9. Chemotherapy 10. Severe psychiatric disease 11. Gram positive bacteria in blood culture 12. Post liver transplant with purulent cholangitis in ERCP

Design outcomes

Primary

Measure	Time frame
Evaluation of occurence of recurrent cholangitis within 4 weeks	—

Countries

Germany

Contacts

Public ContactDirk Walter

Uniklinik Frankfurt

dirk.walter@kgu.de069 6301 5122

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026